Search hospitals > New Mexico > Albuquerque
University of New Mexico
Claim this profileAlbuquerque, New Mexico 87102
Global Leader in Newborns
Global Leader in Cancer
Conducts research for Premature Infants
Conducts research for Low Birth Weight
Conducts research for Small for Gestational Age
373 reported clinical trials
43 medical researchers
Summary
University of New Mexico is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Newborns, Cancer, Premature Infants, Low Birth Weight, Small for Gestational Age and other specialties. University of New Mexico is involved with conducting 373 clinical trials across 534 conditions. There are 43 research doctors associated with this hospital, such as Ursa A. Brown-Glaberman, Carolyn Y. Muller, Kristi L Watterberg, MD, and Davin Quinn, MD.Top PIs
Ursa A. Brown-GlabermanUniversity of New Mexico Cancer Center4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
20 reported clinical trials
45 drugs studied
Carolyn Y. MullerUniversity of New Mexico Cancer Center1 year of reported clinical research
Studies Cancer
Studies Recurrence
20 reported clinical trials
41 drugs studied
Kristi L Watterberg, MDUniversity of New Mexico5 years of reported clinical research
Studies Premature Birth
Studies Premature Infants
7 reported clinical trials
10 drugs studied
Davin Quinn, MDUniversity of New Mexico1 year of reported clinical research
Studies Post-Traumatic Stress Disorder
Studies Traumatic Brain Injury
6 reported clinical trials
8 drugs studied
Clinical Trials running at University of New Mexico
Multiple Sclerosis
Traumatic Brain Injury
Opioid Use Disorder
Urinary Incontinence
Pulmonary Arterial Hypertension
Follicular Lymphoma
Pulmonary Hypertension
Parkinson's Disease
Bedwetting
Liver Failure
Ofatumumab
for Multiple Sclerosis
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Recruiting2 awards Phase 3
Frexalimab
for Multiple Sclerosis
This trial compares a new treatment, frexalimab, with an existing pill, teriflunomide, in adults aged 18-55 who have relapsing multiple sclerosis. The study aims to see if frexalimab can reduce the frequency of symptom relapses better than teriflunomide. Participants will be monitored over several years.
Recruiting1 award Phase 34 criteria
Tolebrutinib
for Primary Progressive Multiple Sclerosis
Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 To evaluate population pharmacokinetics (PK) of SAR442168 in PPMS and its relationship to efficacy and safety To evaluate pharmacodynamics of SAR442168
Recruiting1 award Phase 35 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of New Mexico?
University of New Mexico is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Newborns, Cancer, Premature Infants, Low Birth Weight, Small for Gestational Age and other specialties. University of New Mexico is involved with conducting 373 clinical trials across 534 conditions. There are 43 research doctors associated with this hospital, such as Ursa A. Brown-Glaberman, Carolyn Y. Muller, Kristi L Watterberg, MD, and Davin Quinn, MD.
Where is University of New Mexico located?
To reach the University of New Mexico Hospital in Albuquerque, take I-25 S and exit at Lomas Blvd, then head east on Camino de Salud. The hospital is conveniently located near the intersection of Lomas Blvd and Yale Blvd.
Who should I call to ask about financial aid or insurance network?
**University of New Mexico Hospital Contact Information**
**Financial Assistance:**
- **Phone:** 505-994-7157
- **Email:** ambnchavez@srmc.unm.edu (Amber Chavez), resquibel@srmc.unm.edu (Raymond (Josh) Esquibel)
**Insurance:**
- **Phone:** UNM Hospital (UNMH): 505-272-2521, UNM Sandoval Regional Medical Center (SRMC): 505-994-7468
For more detailed information, refer to the UNM Hospital Financial Assistance Policy.
What insurance does University of New Mexico accept?
The University of New Mexico Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Blue Cross & Blue Shield of NM, Cigna, and United Healthcare. The UNM LoboHealth medical plan, available to active benefits-eligible employees, offers low out-of-pocket costs for Tier 1 services and access to providers in New Mexico and the BCBS national network. For non-emergency services, it's recommended to contact the hospital directly to confirm specific insurance plan acceptance.
What awards or recognition has University of New Mexico received?
The University of New Mexico Hospital, located in Albuquerque, New Mexico, ranks 60th nationally for extramural funding from the National Institute of Health in 2019, showcasing its strong research commitment. It has also earned the Women’s Choice Award® for America’s Best Hospitals Cancer Care, underscoring its excellence in patient care.